Long-term Safety and Efficacy of Empagliflozin as Add on to GLP-1 RA
Clinical trial NCT02589626 · COMPLETED
Trial details
- NCT number
- NCT02589626
- Sponsor
- Boehringer Ingelheim
- Status
- COMPLETED
- Phase
- Phase 4
- Study type
- INTERVENTIONAL
- Start date
- 2015-10-29
- Primary completion
- 2017-06-02
- Enrollment
- 65
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.